Add-on pegylated interferon augments hepatitis B surface antigen clearance vs continuous nucleos(t)ide analog monotherapy in Chinese patients with chronic hepatitis B and hepatitis B surface antigen ≤ 1500 IU/mL: An observational study

doi:10.3748/wjg.v26.i13.1525

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 26, Issue 13

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7266)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-4) series.

Item

Count

PDF

553

WORD

149

HTML

4034

Figures (1-5)

324

Tables (1-4)

248

Sum=5308

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

626

Download

1332

Sum=1958

Apr 7, 2020 (publication date) through Jul 15, 2024

Times Cited of This Article

Times Cited (25)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Gastroenterol. Apr 7, 2020; 26(13): 1525-1539
Published online Apr 7, 2020. doi: 10.3748/wjg.v26.i13.1525

Full Size Figure Download Figure

Figure 4 Virological change. A: Dynamics of hepatitis B surface antigen titers (^bP < 0.001 vs monotherapy group for weeks 12, 24, 36, 48 and 72). Data shown are median values of log₁₀ hepatitis B surface antigen and error bars represent 95% confidence interval. B: HBsAg response at week 72.

Citation: Wu FP, Yang Y, Li M, Liu YX, Li YP, Wang WJ, Shi JJ, Zhang X, Jia XL, Dang SS. Add-on pegylated interferon augments hepatitis B surface antigen clearance vs continuous nucleos(t)ide analog monotherapy in Chinese patients with chronic hepatitis B and hepatitis B surface antigen ≤ 1500 IU/mL: An observational study. World J Gastroenterol 2020; 26(13): 1525-1539
URL: https://www.wjgnet.com/1007-9327/full/v26/i13/1525.htm
DOI: https://dx.doi.org/10.3748/wjg.v26.i13.1525